Data Integrity Problems in an FDA Warning Letter: Lessons
Data integrity findings in a 2022 FDA warning letter: shared admin logins, no audit trail review and weak remediation, explained against 21 CFR 211 and FDA's Q&A.
Data integrity findings in a 2022 FDA warning letter: shared admin logins, no audit trail review and weak remediation, explained against 21 CFR 211 and FDA's Q&A.